PT  - JOURNAL ARTICLE
AU  - Herzberg, Daniel L
AU  - Sukumaran, Harry P
AU  - Viscusi, Eugene
TI  - NSAIDs for analgesia in the era of COVID-19
AID  - 10.1136/rapm-2020-101584
DP  - 2020 Sep 01
TA  - Regional Anesthesia & Pain Medicine
PG  - 677--678
VI  - 45
IP  - 9
4099  - http://rapm.bmj.com/content/45/9/677.short
4100  - http://rapm.bmj.com/content/45/9/677.full
SO  - Reg Anesth Pain Med2020 Sep 01; 45
AB  - Globally, non-steroidal anti-inflammatory drugs (NSAIDs) are highly used to treat pain. With the rise of the COVID-19 pandemic, the safety of NSAIDs use has been called into question. These concerns are worthy of review. At present, there is no compelling data showing that NSAIDs worsen the severity of COVID-19 symptoms or increase one’s likelihood of contracting the illness. For patients in pain and without symptoms that could potentially be attributed to COVID-19 (cough, fevers/chills, lethargy, myalgias, anosmia and so on), NSAIDs should continue to remain a viable option to provide analgesia to patients in need.